Cellular origin of deadly brain cancer is identified
Using a mouse genetic system co-developed by researchers at the University of Oregon and Stanford University, a research team led by UO biologist Hui Zong has isolated the cellular origin for malignant glioma, a deadly human brain cancer.
The discovery that oligodendrocyte precursor cells (OPCs) are the point of origin is reported online July 7 ahead of regular print publication in the July 22 issue of the journal Cell. These OPCs, the researchers said, were the first cells to display "significant overexpansion and aberrant growth."
Malignant glioma is diagnosed in 10,000 Americans annually, with most patients dying within two years. Victims have included U.S. Sen. Ted Kennedy (2009), pianist George Gershwin (1937), marine biologist Thor Heyerdahl (2002) and film critic Gene Siskel (1999).
"The cure for this devastating disease lies in our ability to unequivocally identify the cell-of-origin for gliomagenesis, which would then allow researchers and doctors to harness the intrinsic properties of such cell types to thwart the attack," said Zong, a member of the UO Institute of Molecular Biology.
Zong, also a fan of the UO's football Ducks, likened the search for tumor-igniting cells to setting up a defense designed to stop a quarterback's distribution of the ball to a receiver or running back. "To study cancer, you have to understand the route of attack," he said. "With conventional research methods, we saw a snapshot when the ball goes to the quarterback, and then suddenly we see the touchdown: Cancer, six points. That is obviously not enough for us to understand cancer's attacking strategies."
This video is not supported by your browser at this time.The technique Zong and his team used -- Mosaic Analysis with Double Markers (MADM), developed for studying developmental biology and modeling diseases in mice -- was first described by Zong, co-author Liqun Luo of Stanford University and other colleagues in a paper in Cell in 2005, when Zong was a postdoctoral researcher studying under Luo.
The essence of MADM is its unambiguous labeling of mutant cells with green fluorescent protein, which allowed Zong's team to probe into pre-clinical, tumor-initiating stages that are inaccessible to researchers using conventional tools. "Our system lets us watch the action from the beginning, to watch every direction, every hand off or pass, before a tumor forms," Zong said.
"Another key feature is the concurrent creation of a normal red cell whenever a mutant green cell is generated. In effect, we can compare every player's movement with or without the ball -- the mutations," he said. "If they are doing the same thing, we know they are not attacking. If they are doing different things, we know something is wrong, and should focus our attention to tackle the particular player, the cell type, to prevent a tumor from advancing down the field."
In the current research, funded primarily by the National Institutes of Health, two prevalent mutations found in human glioma patients, p53 and NF1, were introduced into neural stem cells (NSCs) "just like snapping the ball to the quarterback," Zong said. "And to our surprise, the quarterback didn't run, although NSCs have been implicated in gliomagenesis by other research groups using conventional genetic methods."
Further analyses of all cell lineages derived from neural stem cells clearly demonstrated that OPCs are the cell of origin since mutant green OPCs over-populate their normal red counterparts by 130-fold before any visible signs of tumor can be detected. "Therefore," Zong said, "the quarterback role of the NSCs seems to be merely passing the ball to the running back -- the OPCs -- which will then score the touchdown.
To convincingly show that OPCs have intrinsic scoring ability independent of the mutation-passing process from NSCs, researchers in the Zong lab also introduced p53 and NF1 mutations directly into OPCs.
"This time the snap from center actually goes straight to the running back -- a la the wildcat used to perfection since 2008 by the National Football League's Miami Dolphins," Zong said, "and lo-and-behold, gliomas consistently arise in these mice. Now we are convinced that OPC is the cell type that scores for glioma and should become the focus of our defense team."
From a big picture, in addition to the potential to translate this new discovery into clinical diagnosis and treatment, the breakthrough technology should be able to determine the point of ignition in many other cancers, he said.
"It is now obvious that we really need to understand these OPCs," Zong said. "Why do they respond so drastically to these mutations? Which route do they take to become fully malignant tumor cells?"
Data provided by the project inspired a three-year, $1 million grant, awarded to the UO earlier this year, from the W.M. Keck Foundation to study glioma as an evolutionary process.
"Studying cancer in this way should not only lead to molecular diagnostics to detect the earliest emergence of any cancers, but also allow us to understand the molecular mechanisms by which initial mutant cells progressively gain advantages over normal cells," Zong said. "This type of knowledge should eventually enable us to set up multi-point tackling plan to increase the efficacy of cancer treatment."
Provided by University of Oregon
- Looking at cancer progression as evolutionary process Feb 04, 2011 | not rated yet | 0
- 'Gateway' gene discovered for brain cancer Feb 14, 2007 | not rated yet | 0
- eBay buying Zong for $240 million Jul 07, 2011 | not rated yet | 0
- Anti-cancer virus kills brain cancer cells Nov 01, 2006 | not rated yet | 0
- Researchers uncover new potential biomarker and therapeutic target for aggressive breast cancer Apr 29, 2011 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
How can there be a term called "intestinal metaplasia" of stomach
6 hours ago Hello everyone, Ok Stomach's normal epithelium is simple columnar, now in intestinal type of adenocarcinoma of stomach it undergoes "intestinal...
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013 From pressure-volume curve of the lung and chest wall (attached photo), I don't understand why would the elastic recoil pressure of the lung is...
If you became brain-dead, would you want them to pull the plug?
May 17, 2013 I'd want the rest of me to stay alive. Sure it's a lousy way to live but it beats being all-the-way dead. Maybe if I make it 20 years they'll...
MRI bill question
May 15, 2013 Dear PFers, The hospital gave us a $12k bill for one MRI (head with contrast). The people I talked to at the hospital tell me that they do not...
Ratio of Hydrogen of Oxygen in Dessicated Animal Protein
May 13, 2013 As an experiment, for the past few months I've been consuming at least one portion of Jell-O or unflavored Knox gelatin per day. I'm 64, in very...
Alcohol and acetaminophen
May 13, 2013 Edit: sorry for the typo in the title , can't edit I looked around on google quite a bit and it's very hard to find precise information on the...
- More from Physics Forums - Medical Sciences
More news stories
The surgical management of non-small cell lung cancer (NSCLC) in U.S. hospitals varies widely depending on the race of the patient, according to a new study.
Cancer 3 hours ago | not rated yet | 0
Treatment with an Alpha-1 proteinase inhibitor (A1-PI), a naturally occurring protein that protects lung tissue from breakdown and protects the lung's elasticity, is effective in slowing the progression of emphysema in patients ...
Cancer 3 hours ago | not rated yet | 0
Scientists from Nanyang Technological University (NTU) and Lund University, Sweden, have bioengineered a novel molecule which has been proven to successfully kill tumour cells.
Cancer 3 hours ago | 5 / 5 (1) | 0
An article published on the journal Nature describes the major role that Pyruvate dehydrogenase (PDH) —an enzyme of cellular energy metabolism— plays in the regulation of the cellular senescence induce ...
Cancer 4 hours ago | not rated yet | 0
(Medical Xpress)—Scientists at the School of Medicine have shown that their previously identified therapeutic approach to fight cancer via immune cells called macrophages also prompts the disease-fighting killer T cells ...
Cancer 5 hours ago | not rated yet | 0 |
The level of immunity to the recently circulating H7N9 influenza virus in an urban and rural population in Vietnam is very low, according to the first population level study to examine human immunity to the virus, which was ...
1 hour ago | not rated yet | 0 |
Researchers at Emory University have identified a protein that stimulates a pair of "orphan receptors" found in the brain, solving a long-standing biological puzzle and possibly leading to future treatments for neurological ...
1 hour ago | not rated yet | 0 |
You're standing near an airport luggage carousel and your bag emerges on the conveyor belt, prompting you to spring into action. How does your brain make the shift from passively waiting to taking action when ...
13 minutes ago | not rated yet | 0 |
Widely available in pharmacies and health stores, phosphatidylserine is a natural food supplement produced from beef, oysters, and soy. Proven to improve cognition and slow memory loss, it's a popular treatment for older ...
37 minutes ago | not rated yet | 0 |
Prostaglandin analogues (PGAs), drugs which lower intraocular pressure, are often the first line of treatment for people with glaucoma, but their use is not without risks. PGAs have long been associated with blurred vision, ...
1 hour ago | not rated yet | 0
Youth who had a schoolmate die by suicide are significantly more likely to consider or attempt suicide, according to a study in published in CMAJ (Canadian Medical Association Journal). This effect can last 2 years or mo ...
47 minutes ago | not rated yet | 0